Status:
COMPLETED
Use of PARniv for Early Diagnosis of LVF in AECOPD
Lead Sponsor:
University of Monastir
Conditions:
Acute Heart Failure
COPD Exacerbation
Eligibility:
All Genders
18-80 years
Brief Summary
Left ventricular failure (LVF) is a common cause of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This association is frequently underestimated with regard to the difficulty o...
Detailed Description
Acute heart failure (AHF) is a common cause of COPD exacerbation however its role is very often underestimated. Until now, the use of echocardiography and some invasive hemodynamic exploration techniq...
Eligibility Criteria
Inclusion
- patients with a history of COPD
- consulted the emergency department for AECOPD defined by a respiratory rate \>25c/min, SaO2 \<90%, pH \<7.35 and PaCO2 \>6kPa were included.
Exclusion
- hemodynamic instability requiring the use of vasoactive drugs
- patients with contraindications to NIV (Glasgow score \<12, swallowing disorder or severe bronchial obstruction, vomiting, and those with upper airway obstruction or ongoing upper gastrointestinal bleeding and altered bronchial clearance)
- non cooperative patients
- who refused to give consent.
Key Trial Info
Start Date :
January 3 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 3 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05189119
Start Date
January 3 2022
End Date
May 3 2022
Last Update
May 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital of Monastir
Monastir, Tunisia, 5000